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Background: Although national surveillance programs are in place to monitor norovirus epidemiology, the
emergence of new strains and the genetic diversity among genotypes can be challenging for clinical laboratories.
This study evaluated the analytical and clinical performance characteristics of one real-time RT-PCR and two end-point
RT-PCRs commonly used in microbiology laboratories.
Methods: Lower limit of detection (LoD) was determined using 10-fold dilutions of noroviruses belonging to different
genotypes. The clinical performance of the real-time and end-point RT-PCRs was assessed in parallel using nucleic acids
extracted from 186 stool specimens.
Results: The real-time RT-PCR was highly sensitive and specific for the detection of norovirus genotypes that are
currently circulating in Canada. In contrast, the two end-point RT-PCRs displayed poor analytical sensitivity or complete
failure to detect certain norovirus genotypes, which was correlated to sequence mismatches in the primer-binding sites.
In an attempt to improve norovirus detection with the end-point RT-PCRs, both assays were processed concurrently and
detection from either assay was considered a positive result. Concurrent testing resulted in only a modest increase in
clinical sensitivity (75.0%) compared to each assay alone (62.5% and 71.9%). However, the false positivity rate increased
from 1.98% and 3.36% for the assays alone to 5.47% with concurrent testing.
Conclusions: This study emphasizes the benefits of a real-time method and provides support for routine surveillance to
monitor norovirus epidemiology and ongoing proficiency testing to ensure detection of circulating norovirus genotypes.
Keywords: Norovirus, Proficiency testing, Quantitative RT-PCR, Epidemiology, GenotypingBackground
Noroviruses are the leading cause of acute gastroenter-
itis, and outbreaks are common [1,2]. Transmission oc-
curs through the fecal-oral route and is facilitated by a
low infectious dose and environmental persistence [1,2].
Laboratory identification of norovirus can help reduce
transmission through infection control and public health
interventions [2]. Since human noroviruses are uncultiv-
able, traditional detection methods relied primarily on
electron microscopy and enzyme immunoassays, both of
which lack sensitivity [2-5]. RT-PCR has markedly im-
proved the detection of noroviruses and has become the* Correspondence: Jason.leblanc@cdha.nshealth.ca
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unless otherwise stated.method of choice for clinical diagnosis [2]. However, the
genetic diversity among noroviruses poses a particular
challenge for molecular assays [6-11]. Noroviruses are
classified into six genogroups, three of which cause hu-
man disease (GI, GII, and GIV) [12-14]. The two pre-
dominant genogroups, GI and GII, are further subdivided
into 9 and 22 genotypes, respectively [12-14]. Strategies
used to overcome norovirus diversity have included the
simultaneous use of various monoplex RT-PCRs, multi-
plexed RT-PCRs, RT-PCRs with degenerate primers and
probes [8-11,15-19].
The dynamic nature of its epidemiology poses further
challenges for laboratory detection of norovirus. While
genotype GII.4 is responsible for the majority of out-
breaks annually, new GII.4 strains emerge every 2–3 years
that replace the previously circulating pandemic strain
[14,20-25]. Norovirus GII.4-2012 Sydney has recentlyl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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wide [14,20-26], including the Canadian provinces of
Alberta [25], British Columbia [27] and recently, Nova
Scotia (unpublished data). In addition, the proportion of
outbreaks associated with non-GII.4 genotypes has in-
creased in Canada and the US, and the predominant non-
GII.4 genotypes change over time [14,23,25,28]. With the
diversity among norovirus genotypes and the dynamic na-
ture of its epidemiology, this study evaluated the analytical
and clinical performance of a real-time RT-PCR and two
end-point RT-PCRs (EP-SR and EP-JV) commonly used
for the detection of noroviruses in clinical, food and envir-
onmental laboratories [8-11,16,17,29-36].
Results
Analytical sensitivity and specificity
Each method was specific for circulating noroviruses
(Table 1) and no cross-reactions occurred with various
enteric pathogens. The real-time RT-PCR was able to
detect all norovirus genotypes with high sensitivity
(Table 1). EP-JV detected all GII.4 strains, but only a
subset of non-GII.4 genotypes. EP-SR only detected
GII.4 strains. For GII.4 noroviruses, real-time RT-PCR
was approximately 10-fold more sensitive than EP-JV,
and 100-fold more sensitive than EP-SR (Table 1). Simi-
larly, the LoD for different GII.4 strains were highly
consistent for EP-JV. For EP-SR, only minor differ-
ences in the LoD for GII.4 strains from 2004 to 2009,
but a 100-fold decrease in sensitivity was observed forTable 1 Limit of detection and specificity analysis





GI.1 (2011) 2.21 ND* ND
GI.3 (2008) 2.27 ND ND
GI.4 (2008) 2.67 ND ND
GI.6 (2010) 2.11 5.96 ND
Norovirus, genotype GII (non-GII.4)
GII.1 (2011) 2.37 5.54 ND
GII.3 (2006) 2.52 ND ND
GII.7 (2010) 2.57 ND ND
GII.13 (2010) 2.14 ND ND
Norovirus, genotype GII.4
GII.4 (2004) Den Haag 2.20 3.56 4.55
GII.4 (2006b) Osaka 2.47 3.37 4.32
GII.4 (2009) New Orleans 2.85 3.53 4.52
GII.4 (2012) Sydney 2.61 3.71 6.62
*ND signifies not detected at a minimal concentration of 106 copies/ml.GII.4-2012. Reduced sensitivity was also observed with
EP-JV for genotypes GI.6 and GII.1.
Clinical evaluation
The clinical sensitivity of the real-time RT-PCR and
end-point RT-PCR assays (EP-JV and EP-SR) was 100%,
71.9%, and 62.5%, respectively (Table 2). With concur-
rent testing of EP-JV and EP-SR, the clinical sensitivity
was only modestly increased to 75% compared to each
assay alone, since both EP-JV and EP-SR failed to detect
8 genotype GII.7 noroviruses (Table 3). EP-JV alone also
missed a genotype GII.15 and EP-SR missed three geno-
type GI.6 noroviruses and one GI.3 (Table 3). With the
exception of the latter, viral loads were above their LoD
for all methods and the poor sensitivity of EP-JV and
EP-SR was correlated to sequence mismatches in the
primer-binding sites (Table 1 and Figure 1).
As non-specific amplifications were observed for both
EP-JV and EP-SR, concurrent testing resulted in a re-
duced clinical specificity (94.8%) compared to each
method alone (98.1% and 96.8%, respectively) (Table 2).
The false positivity rate for concurrent testing was
increased to 5.47% compared to 1.98% and 3.36% for
EP-JV and EP-SR alone. A two-year retrospective ana-
lysis revealed that 14 outbreaks were declared by a single
EP-JV and EP-SR result where weak amplifications were
noted, suggesting a possible false positivity rate of 4.8%
for years 2011 and 2012 (Additional file 1: Table S2). As
no differences were observed between real-time RT-PCR
and the reference methods, the real-time RT-PCR was
highly specific (100%) and no false positives were ob-
served (Tables 2 and 3).
Discussion
Genomic diversity and evolutionary change can be chal-
lenging for detection of noroviruses [2,37,38]. While detec-
tion of noroviruses using RT-PCR is far more accurate
than antigen-based detection methods (i.e. EIAs), not all
molecular methods are created equal [2-4]. Fortunately,
most reference laboratories use a real-time RT-PCR target-
ing the most conserved region of the genome (ORF1-
ORF2 junction) and use degenerate primers and probes
that can tolerate some sequence mismatches [9,10]
(Figure 1). In this study, this same real-time RT-PCR was
able to detect diverse norovirus genotypes with analytical
sensitivities consistent with values previously reported
for GII.4 (2006b) (Table 1) [6]. In contrast, EP-JV and
EP-SR were far less sensitive and failed to detect certain
genotypes (Tables 1, 2 and 3). With hopes to enhance
detection of circulating norovirus genotypes, EP-JV and
EP-SR were processed concurrently and detection from
either assay was considered a positive result. Concur-
rent testing only modestly improved clinical sensitivity
(Table 2) since the majority of false negative results
Table 2 Clinical performance characteristics compared to the modified gold standard
Method Clinical Parameters*
Sensitivity (%) Specificity (%) Kappa False positivity rate (%)
Real-time RT-PCR 100.0 (91.5 – 100.0) 100.0 (98.2 – 100.0) 1.00 (0.90 – 1.00) 0.00
EP-JV 71.9 (58.6 – 71.9) 98.1 (95.3 – 99.5) 0.76 (0.58 – 0.84) 1.99
EP-SR 62.5 (48.4 – 71.7) 96.8 (93.8 – 98.7) 0.65 (0.46 – 0.77) 3.36
EP-JV and EP-SR 75.0 (60.3 – 85.5) 94.8 (91.7 – 97.0) 0.70 (0.52 – 0.82) 5.47
*When applicable, 95% confidence intervals are indicated in parentheses.
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Interestingly, failure of EP-JV and EP-SR to detect cer-
tain genotypes was not attributed to poor analytical
sensitivity since the viral load in most clinical specimens
far exceeded the LoD for each assay (Tables 1 and 3). In-
stead, the genotypes that failed to be detected for EP-JV
(GII.7, GII.15) and EP-SR (GII.7, GI.6, and GI.3) were
linked to several sequence mismatches in the primer-
binding sites (Figure 1). Of note, a large norovirus out-
break in Sweden was missed due to mismatches in the
primer-binding sites of JV12 and JV13 (same used for
EP-JV), but were detected by another primer pair [31].
It should also be noted that real-time RT-PCR and
EP-JV both detected genotype GI.3 in a specimen with
a very low viral load (2.47 log10 copies/ml), whereas
EP-JV were unable to detect this genotype at concen-
trations exceeding 6.0 log10 copies/ml in the specificity
analysis (Tables 1 and 3). This confounding result might
be explained by genetic differences between the noro-
virus GI.3 identified in the clinical evaluation and the one
used for the specificity analysis. A 12% nucleotide differ-
ence was noted between GI.6 and GI.7 genotypes that
circulated in Canada between 2009 and 2010 compared
to 2012 and 2013, suggesting that diversity among the
same genotype can occur over time [24]. It is also pos-
sible that the faint amplicon detected by EP-JV was a
false positive result in a specimen that was coincidently
positive by real-time RT-PCR (Table 3).
While concurrent testing marginally increased the clin-
ical sensitivity, a reciprocal effect was seen on the clinical
specificity where the false positivity rate was higher withTable 3 Discordant results obtained during the clinical evalua
No. RT-PCR results Discordant analysis
Real-time RT-PCR EP-JV EP-SR Result Genotype
5 Neg. Neg. Pos. Neg. N/A
3 Neg. Pos. Neg. Neg. N/A
8 Pos. Neg. Neg. Pos. GII.7
3 Pos. Pos. Neg. Pos. GI.6
1 Pos. Pos. Neg. Pos. GI.3
1 Pos. Neg. Pos. Pos. GII.15
Abbreviations: FN false negative, FP false positive, N/A not applicable, Neg. Negativeconcurrent testing (5.47%) than either method alone
(1.98% and 3.36% for EP-JV and EP-SR, respectively)
(Table 2). Upon review of the false positive results, only
faint or non-specific amplifications were noted and likely
attributed to the low annealing temperature of EP-JV
(37°C) or lack of electrophoretic resolution between
primer dimmers and the small amplicon generated with
EP-SR of 123 bp. The subjectivity of gel resolution is
not a problem for a properly validated real-time RT-
PCR [9,10,39].
Following a two-year retrospective analysis of EP-JV
and EP-SR results, 14 of 113 outbreaks investigated in
2011 and 2012 were declared positive by a single result
where weak amplification was observed (Additional file 1:
Table S2). This supports the high false positivity rate
observed during the clinical evaluation (Table 2). Previ-
ous studies have demonstrated that three specimens are
ideal for the detection of norovirus outbreaks using RT-
PCR, but excessive testing can lead to reduced specificity
[5,40,41]. In this study, concurrent testing with multiple
RT-PCRs was shown to increase the rate of false positive
results, which could prematurely halt outbreak investiga-
tions caused by other enteric pathogens that might be
managed differently [2].
Conclusions
Unlike the high clinical sensitivity and specificity ob-
served with real-time RT-PCR, this study demonstrated
that end-point RT-PCRs had poor accuracy for the detec-
tion of circulating norovirus genotypes. To monitor nor-
ovirus epidemiology, genotyping should be consideredtion
Interpretation Comments
FP (EP-SR) Non-specific amplification
FP (EP-JV) Non-specific amplification
FN (EP-JV and EP-SR) High viral loads (5.28 to 7.78 log10 copies/ml)
FN (EP-SR) High viral loads (5.29 to 5.74 log10 copies/ml)
FN (EP-SR) Low viral load (2.47 log10 copies/ml)
FN (EP-JV) High viral load (6.33 log10 copies/ml)
, No. number, Pos. positive.
Figure 1 Sequence alignment of the primer and probe binding sites. Primer pairs JV12/JV13 and SR33/SR46 are A) endpoint RT-PCR assays;
B) real-time RT-PCR. Mismatches between the primer/probe sequences are indicated by a shaded font and are underlined. Genbank accession
numbers are as follows: GI.1 (2011), KF039733.1; GI.3 (2008), JN603244.1; GI.4 (2008), JN603245.1; GI.6 (2010), JQ388274.1; GII.1 (2011), KC597150.1;
GII.3 (2006), GU980585.1; GII.7 (2010), JQ750988.1; GII.13 (2010), JX439807.1; GII.4 (2004), JQ798158.1; GII.4 (2006b), AB447442.1; GII.4 (2009),
GU445325.2; GII.4 (2012), JX459908.1. Abbreviations: B = C, G, or T; R = A or G; Y = C or T; I = A, C, G, or T.
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identified as the etiological agent. Unlike well established
networks like Calicinet and Noronet, norovirus surveil-
lance in Canada is in its infancy [2,14]. Ideally, sequencing
would be used to encompass the regions required for
genotyping and the primer/probe-binding sites for com-
monly used RT-PCRs [42,43]. When sequence mismatches
are identified in RT-PCR target regions or when new nor-
ovirus variants emerges, proficiency panels should be
promptly disseminated to clinical laboratories to ensure
accurate detection [6]. With the dynamic nature of noro-
virus epidemiology, this study highlights the importance
of routine surveillance and ongoing proficiency testing for
circulating norovirus genotypes.Materials and methods
Specimen preparation
For the clinical evaluation, 186 stool specimens were ob-
tained from patients with acute gastroenteritis between
March 15 and June 26, 2013. Public Health outbreak
investigation data was provided by the Department of
Health and Wellness (Halifax, NS) (Additional file 1:
Table S2). Stool slurries were prepared by transferring
200 μl of stool into 500 μl of PCR-grade water and centri-
fugation (10,000 × g, 10 min). The supernatants (140 μl)
were subjected to a total nucleic acid (TNA) extraction
on a MagNA Pure LC instrument (Roche Diagnostics,
Branchburg, NJ), as recommended by the manufacturer.
TNAs were eluted in a volume of 60 μl and 5 μl served as
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in parallel). Primers were synthesized by Sigma Genosys
(Oakville, ON) and probes by Integrated DNA Tech-
nologies (Toronto, ON).
Analytical specificity was performed using high titer
total nucleic acids extracted from norovirus stool suspen-
sions of various genotypes obtained from collaborating
laboratories and concentrated suspensions (MacFarlane
value of 2.0) of various enteric pathogens that included:
adenovirus type 40 (ATCC VR-931); Camplobacter
jejeuni (ATCC 33291); Clostridium difficile (ATCC
9689); Escherichia coli O157:H7 (ATCC 35150); Rota-
virus A (ATCC VR-2018); Salmonella enterica serovar
Typhymirium (ATCC 14028); sapovirus (5 clinical isolates);
Shigella flexneri (ATCC 12022); Shigella dysenteriae
(ATCC 13313); Yersinia enterocolitica (ATCC 9610);
Vibrio cholerae (clinical isolate). To assess the LoD,
10-fold serial dilutions of nucleic acids extracted from
various norovirus genotypes were performed on speci-
mens that had a minimum concentration of 106 copies/
ml. LoD was defined at a probability of 95% using Probit
analysis [44] with replicate values obtained in three inde-
pendent experiments (n = 9).
End-point RT-PCRs
EP-JV and EP-SR RT-PCR assays were performed using
a OneStep RT-PCR kit (Qiagen Inc., Mississauga, ON) in
50 μl reactions consisting of: 2 μl enzyme mix, 1× buffer,
400 μM dNTPs, 20 U RNaseOUT (Life Technologies,
Burlington, ON), and 1.0 μM of each primer (JV12/JV13
for EP-JV or SR33/SR46 for EP-SR) (Additional file 2:
Table S1). Amplifications were performed on a DNA
Dyad Engine (Bio-Rad Laboratories Ltd., Mississauga, ON)
as follows: 50°C for 30 min; 95°C for 15 min; and 40 cy-
cles of 95°C for 1 min, 37°C (EP-JV) or 50°C (EP-SR)
for 1 min, and 72°C for 1 min, followed by a final ex-
tension of 10 min at 72°C. Amplicons were resolved by
1% agarose gel electrophoresis with ethidium bromide
staining. Expected sizes for EP-JV and EP-SR were 327
and 123 bp, respectively.
Real-time RT-PCR
Real-time RT-PCR was performed in duplexed reactions
by combining primers and probes commonly used for GI
ad GII noroviruses (Additional file 2: Table S1). Briefly,
PCR amplifications were performed on a Life Technologies
ABI 7500 Fast instrument in 25 μl reactions consisting of:
SuperScript III Platinum One-Step 1× master mix (Life
Technologies), 0.2 μl enzyme mix, 20U RNaseOUT, and
400 nM of each primer and probe (Additional file 2:
Table S1). Amplification conditions were as follows: 50°C
for 30 min; 95°C for 30s; and 45 cycles of 95°C for 30s and
60°C for 1 min. Ct values were determined using the man-
ufacturer's software (version 2.0.5).Discordant analysis and norovirus genotyping
Clinical sensitivity and specificity were calculated in
comparison to a modified gold standard defined as con-
cordant positive and negative results between real-time
and end-point RT-PCRs (Table 2). Any discordant re-
sults were resolved by at the National Microbiology La-
boratory (NML) using real-time RT-PCR with the same
primers/probes but in monoplex reactions for GI and
GII noroviruses (Additional file 2: Table S1). Since mono-
plex and duplex real-time RT-PCR targets were identical,
a second reference method was also performed at the
NML using RT-PCR amplification and sequencing of
the norovirus major capsid protein regions C and D
(Additional file 2: Table S1). The resulting sequence data
was used for genotype assignment. Briefly, region C and
D RT-PCR reactions were performed using a One-Step
RT-PCR kit (Qiagen) in 50 μl reactions consisting of: 2 μl
enzyme, 1× buffer, 400 nM dNTPs, 40 units of RNase
Inhibitor, 10 μl of template, and 500 nM each primer
(except CapB1 and CapD1 used at 1 μM) (Additional
file 2: Table S1). Amplification conditions were as follows:
42°C for 30 min; 95°C for 15 min; 40 cycles of 94°C for
30s, 40°C (region D) or 50°C (region C) for 30s and 72°C
for 30s; and a final extension of 72°C for 10 min. Following
2% agarose gel electrophoresis, amplicons were purified
using Amicon Filter Devices (Millipore, USA) and sequen-
cing was carried out by the Genomics Core section of the
NML using primers CapA, CapB1, CapC, or CapD1.
Norovirus genotyping and sequence alignments
BioNumerics 5.1 software (Applied Maths, Austin, TX)
was used to assemble consensus sequence data, pairwise
and global alignments, and clustering analysis. The se-
quences of each region were compared to ViroNet Canada
reference dataset for genotype assignment.
To compare primer/probe binding sites to the target
sequences of circulating norovirus genotypes (Figure 1),
sequence data was retrieved from the Genbank database
on the NCBI website (www.ncbi.nlm.nih.gov) and pair-
wise sequence alignments were performed using the
Basic Local Alignment Search Tool (BLAST) function.
Quantification of noroviruses
Norovirus genome equivalents were estimated in rela-
tion to a standard curve generated using plasmids har-
boring GI.4 (2008) and GII.4 (2006b) target sequences.
RNA extracted from characterized stool specimens was
used as template in 25 μl RT-PCR reactions consisting
of: 1x One-Step RT-PCR buffer (Qiagen), 400 μM
dNTPs, 0.4 μM of each primer (COG1F/COG1R for GI
and COG2F/COG2R for GII) (Additional file 2: Table S1),
1 μl enzyme mix, and 4U RNaseOUT. Amplification con-
ditions were as following: 42°C for 30 min; 95°C for
15 min; 45 cycles of 94°C for 30s, 50°C for 30s and 72°C
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Purified amplicons were cloned into pCR 2.1-TOPO
vectors using a TOPO TA Cloning Kit according to
manufacturer’s instructions (Life Technologies) and in-
serts were confirmed by DNA sequencing on a 3130XL
Genetic Analyzer (Life Technologies) at Health Canada
(Ottawa, ON). Following spectrophotometric quantifica-
tion, 10-fold serial dilutions of the plasmids were used as
template for the real-time RT-PCR. Ct values were plotted
against plasmid concentration, generating inverse linear
relationships [for GI (y = −3.44x + 42.13; R2 = 0.9995) and
for GII (y = −3.53x + 41.63; R2 = 0.9998)]. Viral loads
were expressed as log10 copies/ml and represent the aver-
age of triplicate values obtained in three independent
experiments (n = 9).
Statistical analysis
Chi-square and two-tailed Fisher's exact tests were used
to compare proportions in 2-by-2 contingency tables.
Binomial 95% confidence intervals and kappa statistics
for each parameter were calculated by the "constant chi-
square boundaries" method [45] using StatsPlus version
5.8.4.3 (AnalystSoft, Inc.).
Additional files
Additional file 1: Table S2. Retrospective analysis of gastrointestinal
outbreaks in Nova Scotia.
Additional file 2: Table S1. Primer and probes used in this study
[8-11,46,47].
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